FDA Approves 1st New Drug for Schizophrenia in Over 30 Years 

This post was originally published on this site

Addiction Recovery Bulletin

VIDEO – WHAT TOOK THEM SO LONG? –

Sept. 26, 2024 – “This drug takes the first new approach to schizophrenia treatment in decades,” Farchione continued. “This approval offers a new alternative to the antipsychotic medications people with schizophrenia have previously been prescribed.” Cobenfy offers new hope for people with schizophrenia … providing an innovative treatment option that could change how this condition is managed, according to Jelena Kunovac, MD, a board-certified psychiatrist and adjunct assistant professor at the University of Nevada, Las Vegas, in the Department of Psychiatry.

“We are overdue for a medication that targets schizophrenia with a different mechanism of action,” Kunovac told ABC News.

CONTINUE@ABCNews

The post FDA Approves 1st New Drug for Schizophrenia in Over 30 Years  appeared first on Addiction/Recovery eBulletin.